Potential acquirers are exploring the purchase of Gemini's shuttered European and UK operations to bypass lengthy licensing processes. The Nasdaq-listed exchange has faced severe headwinds, with its share price plummeting over 80% since its 2025 IPO.
- Interest focused on UK/EU regulatory licenses, not a full company acquisition
- GEMI shares trading at $4.36, down >80% from IPO price
- Recent exit from UK, EU, and Australian markets
- Significant executive turnover including COO, CFO, and CLO
- Short interest currently at 15% of the float
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.